The ISPOR Asia Consortium is comprised of professionals interested in promoting health economics and outcomes research (HEOR) excellence to improve health care decision making in Asia-Pacific and globally. The Asia Consortium provides a platform for information-sharing and institutional collaboration on HEOR and health policy, facilitating professional networking opportunities through scientific activities and global ISPOR initiatives.

2018 ISPOR Tokyo CFA

8th Asia-Pacific Conference
8-11 September 2018
Tokyo, Japan

Abstract Submission Opens: Wednesday, 1 November 2017
Abstract Submission Deadline: Wednesday, 14 March 2018
Early Registration Deadline:Tuesday, 17 July 2018


ViH Reginal Issue-Asia

Value in Health Regional Issues (ViHRI) is a Medline indexed, scientific, peer-reviewed journal to encourage and enhance the science of pharmacoeconomic/health economic and health outcomes research and its use in health care decisions in Asia-Pacific. Manuscript submission is open year-round.
Submit a Manuscript »

News Across Asia

News Across Asia
ISPOR Asia Consortium newsletter

The ISPOR Book of Terms
The ISPOR Book of Terms
Now Available in Japanese, Bahasa Indonesian and Mongolian!
  1. Introduction to Pharmacoeconomics (药物经济学导论)
  2. Introduction to Outcomes Research (产出研究)
  3. Use of Public Survey Data in Health Outcomes Research (健康相关生存质量:基础)
  4. Health-Related Quality of Life (HRQOL) – Basics (在卫生结果研究中使用公用调查数据)
  5. Introduction to Systematic Reviews & Meta-Analysis (关于系统综述和荟萃分析的介绍)
  6. PRO: Analysis and Interpretation (患者报告结果 - 分析与解读)

Health Care in Asia-Pacific


Membership of the Asia Consortium is open to all interested individuals in and outside of Asia.


Asia Pacific Observatory on Health Systems and Policies (APO) released the HiT review of Japan

Now Available! The Japanese Pharmacoeconomic (PE) Guidelines are now on the ISPOR website!
Thanks to the ISPOR Japan Chapter for updating the key feature form. The information is available here